All Posts By

CND Life Sciences

Dr. Todd Levine Talks With Medical World News About the Potential of the Syn-One Test™ to Impact Patients’ Care

By In the News

Todd Levine, MD, Co-Founder and Chief Medical Officer of CND Life Sciences was recently interviewed on Medical World News about the development of the Syn-One Test, how it can lead to better clinical decision making, and its potential to significantly impact the lives of patients with Parkinson’s disease, dementia with Lewy bodies, pure autonomic failure, and multiple system atrophy.

Read More

Response to the S4 Study Results in Neurology

By In the News

A group of international experts responded to the publication of the recent Systemic Synuclein Sampling Study (S4), which found alpha-synuclein to be a specific—but not sensitive—marker of Parkinson’s disease. Their letter details how the study’s methods, rather than the specificity of alpha-synuclein as a marker for Parkinson’s disease, may have produced the results.

Read More